Orphan Diseases Therapeutics Market to 2018

Orphan Diseases Therapeutics Market to 2018

The challenges in developing drugs for orphan indications are significant, but large pharmaceutical companies are showing increasing interest in the area and entering the market through strategic acquisitions and licensing agreements with smaller companies that have a strong research focus, as demonstrated by Sanofi’s acquisition of Genzyme, a leader in orphan neurometabolic disorders. The need for curative therapies is acute and presents a good opportunity for companies who can get a disease-modifying therapy to market. With the pipelines for diseases such as multiple myeloma containing several promising late-stage candidates that may receive approval over the next five years, the markets for orphan indication therapeutics are a growth area.

Request a Sample for or Inquire before buying the report @ 

http://www.reportsnreports.com/reports/140394-orphan-diseases-therapeutics-market-to-2018.html

Scope

• Annualized market data for the orphan diseases therapeutics market from 2002 to 2011, forecast to 2018
• Analysis of the leading therapeutic segments. These include Fabry Disease, Pompe Disease and Mucopolysaccharidosis.
• Analysis of the orphan diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
• Market characterization of the orphan diseases therapeutics market including market size, annual cost of therapy, and treatment usage patterns
• Key drivers and barriers that have a significant impact on the market
• Coverage of pipeline molecules in various phases of drug development
• Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche, Genzyme Corporation, Novartis AG, Celgene Corporation, Orphan Europe, Pfizer Inc, Actelion Pharmaceuticals and Shire Plc.
• Key M&A activities, licensing agreements, that have taken place between 2009 and 2011 in the global orphan diseases therapeutics market

Explore Comprehensive list of more than Tables & Figures available in the report “Orphan Diseases Therapeutics Market to 2018“